フォロー
Suhaila O. Alhaj Suliman
Suhaila O. Alhaj Suliman
PhD in Pharmaceutical Sciences
確認したメール アドレス: uiowa.edu
タイトル
引用先
引用先
Engineering nanosystems to overcome barriers to cancer diagnosis and treatment
SO Alhaj-Suliman, EI Wafa, AK Salem
Advanced drug delivery reviews 189, 114482, 2022
362022
New 1, 2, 3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization
HHH Mohammed, AA Abd El-Hafeez, K Ebeid, AI Mekkawy, ...
Journal of enzyme inhibition and medicinal chemistry 37 (1), 1346-1363, 2022
362022
Cationic nanoparticles enhance T-cell tumor infiltration and antitumor immune response to a melanoma vaccine
R Smith, EI Wafa, SM Geary, K Ebeid, SO Alhaj-Suliman, AK Salem
Science Advances, 2022
322022
Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice
AI Mekkaw, YW Naguib, SO Alhaj-Suliman, EI Wafa, K Ebeid, T Acri, ...
International Journal of Pharmaceutics, 2021
162021
Ciprofloxacin derivative‐loaded nanoparticles synergize with paclitaxel against type II human endometrial cancer
YW Naguib, SO Alhaj‐Suliman, EI Wafa, S Saha, K Ebeid, ...
Small 20 (41), 2302931, 2024
102024
A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer
SO Alhaj-Suliman, YW Naguib, EI Wafa, S Saha, K Ebeid, X Meng, ...
Biomaterials 296, 122093, 2023
102023
Polymeric particles as cancer vaccine vectors
SO Alhaj-Suliman, EI Wafa, SM Geary, AK Salem
American Pharmaceutical Review 22 (3), 32-39, 2019
5*2019
Model-based meta-analysis to compare primary efficacy-endpoint, efficacy-time course, safety, and tolerability of opioids used in the management of osteoarthritic pain in humans
SO Alhaj-Suliman, G Milavetz, AK Salem
Current drug metabolism 21 (5), 390-399, 2020
22020
Injectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: in vitro characterization and in vivo …
DS Nakhla, AI Mekkawy, YW Naguib, AD Silva, D Gao, JA Kim, ...
International journal of pharmaceutics 650, 123693, 2024
12024
Compositions and methods for treating cancer
AK Salem, K Ebeid, YWN Ibrahim, S Saha, EI Wafa, S Alhaj-Suliman
US Patent App. 17/890,757, 2024
2024
Compositions and methods for treating cancer
KE Aliasger K. Salem, Youssef W. Naguib, Suhaila O. Alhaj-Suliman, Emad I ...
US Patent App. 63/234,492, 2021
2021
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–11